Page last updated: 2024-09-02

1-hexadecyl-2-acetyl-glycero-3-phosphocholine and sulprostone

1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with sulprostone in 2 studies

Compound Research Comparison

Studies
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)
Trials
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)
Recent Studies (post-2010)
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)
Studies
(sulprostone)
Trials
(sulprostone)
Recent Studies (post-2010) (sulprostone)
9,1561875524415850

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ahluwalia, A; Perretti, M1
Jones, RL; Matthews, JS1

Other Studies

2 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and sulprostone

ArticleYear
Anti-inflammatory effect of prostanoids in mouse and rat skin: evidence for a role of EP3-receptors.
    The Journal of pharmacology and experimental therapeutics, 1994, Volume: 268, Issue:3

    Topics: Alprostadil; Animals; Anti-Inflammatory Agents, Non-Steroidal; Blood; Dinoprostone; Edema; Male; Mice; Misoprostol; Platelet Activating Factor; Rats; Rats, Wistar; Receptors, Prostaglandin E; Skin; Zymosan

1994
Potentiation of aggregation and inhibition of adenylate cyclase in human platelets by prostaglandin E analogues.
    British journal of pharmacology, 1993, Volume: 108, Issue:2

    Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Adenylyl Cyclase Inhibitors; Adenylyl Cyclases; Dinoprostone; Drug Synergism; Humans; Platelet Activating Factor; Platelet Aggregation; Prostaglandin Antagonists; Prostaglandin Endoperoxides, Synthetic; Prostaglandins E, Synthetic; Xanthenes; Xanthones

1993